| Description | Eptinezumab, a human monoclonal antibody, specifically binds to and blocks the calcitonin gene-related peptide (CGRP) from binding to its receptor, thus acting as a preventive treatment for migraine in adults [1]. |
| molecular weight | N/A |
| CAS | 1644539-04-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |